Cytokines and Chemokines in HIV Infection: Implications for Therapy

References

• Aukrust P., Liabakk N. B., Muller F., Lien E., Espevik T., Froland S. F. Serum levels of tumor necrosis factor-a and soluble TNF receptors in human immunodeficiency virus type 1 infection. Correlations to clinical, immunologic, and virologic parameters. J. Inf. Dis. 1994; 169: 420–424
   PubMed Web of Science ®Google Scholar
• Birx D. L., Redfield R. R., Tencer K., Fowler A., Burke D. S., Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76: 2303–2310
   PubMed Web of Science ®Google Scholar
• Breen E. C., Rezal A. R., Nakajima K., Beall G. N., Mitsuyasu R. T., Hirano T., Kishimoto T., Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 1990; 144: 480–484
   PubMed Web of Science ®Google Scholar
• Weiss L., Haeffner-Cavaillon N., Laude M., Gilquin J., Kazatchkine M. D. HIV infection is associated with the spontaneous production of interleukin-1 in vivo and with an abnormal release of IL-1a in vitro. AIDS 1989; 3: 695–699
   PubMed Web of Science ®Google Scholar
• Emilie D., Peuchmaur M., Maillot M.-C, Crevon M.-C, Brousse N., Delfraissy J. F., Dormont J., Galanaud P. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 1990; 86: 148–159
   PubMed Web of Science ®Google Scholar
• Graziosi C., Pantaleo G., Gantt K. R., Fortin J. P., Demarest J. F., Cohen O. J., Sékali R. P., Fauci A. S. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected patients. Science 1994; 265: 248–252
   PubMed Web of Science ®Google Scholar
• Westendorp M. O., Shatrov V. A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P. H., Dräge W., Lehman V. HIV-1 Tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state. EMBO J. 1995; 14: 546–554
   PubMed Web of Science ®Google Scholar
• Borghi P., Fantuzzi L., Varano B., Gessani S., Puddu P., Conti L., Rosaria M., Capobianchi M. R., Ameglio F., Belardelli F. Induction of Interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J. Virol. 1995; 69: 1284–1287
   PubMedGoogle Scholar
• Akridge R. E., Oyafuso L. K.M., Reed S. G. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol. 1994; 153: 5782–5789
   PubMedGoogle Scholar
• Masood R., Lunardi-Iskandar Y., Moudgil T., Zhang Y., Law R. E., Huang C. L., Puri R. K., Levine A. M., Gill P. S. IL-10 inhibits HIV-1 replication and is induced by tat. Biochem. Biophys. Res. Commun. 1994; 202: 374–383
   PubMed Web of Science ®Google Scholar
• Ameglio F., Capobianchi M. R., Castilleti C., Cordiali-Fei P., Fais S., Trento E., Dianzani F. Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells. Correlation with the induction of other cytokines. Clin. Exp. Immunol. 1994; 95: 455–458
   PubMedGoogle Scholar
• Emilie D., Fior R., Llorente L., Marfaing-Koka A., Peuchmaur M., Devergne O., Jarrousse B., Wijdenes J., Boue F., Galanaud P. Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol. Rev. 1994; 140: 5–34
   PubMed Web of Science ®Google Scholar
• Emilie D., Fior R., Crevon M. C., Maillot M. C., Boue F., Galanaud P. Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease. Res. Immunol. 1995; 145: 595–604
   Google Scholar
• Denis M., Ghadirian E. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res. Hum. Retroviruses 1994; 10: 1619–1627
   PubMedGoogle Scholar
• Gallo P., Sivieri S., Rinaldi L., Yan X. B., Lolli F., DeRossi A., Tavolato B. Intrathecal synthesis of interleukin 10 in viral and inflammatory diseases of the central nervous system. J. Neurol. Sci. 1994; 126: 49–53
   PubMed Web of Science ®Google Scholar
• Rimaniol A. C., Boussin F., Herbelin A., DeGroote D., Dormont D., Bach J. F., Descamps-Latscha B., Zavala F. Induction of soluble tumor necrosis factor receptor (sRNF-R75) release by HIV adsorption on cultured human monocytes. Eur. J. Immunol. 1994; 24: 2055–2060
   PubMed Web of Science ®Google Scholar
• Godfried M. H., Van der Poll T., Weverling G. J., Mulder J. W., Jansen J., VanDeventer S. J.H., Sauerwein H. P. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. 1994; 169: 739–745
   PubMed Web of Science ®Google Scholar
• FrissenJos P. H., Weverling G. J., Endert E., Jansen J., Sauerwein H. P., Lange J. Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection. JAIDS 1996; 12: 482–488
   Google Scholar
• Billelo J. A., Stellrecht K., Drusano G. L., Stein D. S. Soluble tumor necrosis factor-α receptor type II (sTNFαRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J. Inf. Dis. 1996; 173: 464–467
   PubMedGoogle Scholar
• Chehimi J., Starr S. E., Frank I., D'Andrea A., Ma X., MacGregor R. R., Sennelier J., Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 1994; 179: 1361–1366
   PubMed Web of Science ®Google Scholar
• Harrison T. S., Levitz S. M. Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol. 1996; 156: 4492–4497
   PubMedGoogle Scholar
• Chougnet C., Wynn T. A., Clerici M., Landay A. L., Kessler H. A., Rusnak J., Melcher G. P., Sher A., Shearer G. M. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J. Inf. Dis. 1996; 174: 46–53
   PubMedGoogle Scholar
• Lane H. C., Depper J. M., Greene W. C., Whalen G., Waldmann T. A., Fauci A. S. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 1985; 313: 79–84
   PubMed Web of Science ®Google Scholar
• Clerici M., Hakim F. T., Venzon D. J., Blatt S., Hendrix C. W., Wynn T. A., Shearer G. M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 1993; 91: 759–765
   PubMed Web of Science ®Google Scholar
• Meyaard L., Schuitemaker H., Miedema F. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function. Immunol. Today 1993; 14: 161–164
   PubMedGoogle Scholar
• Cefai D., Debre P., Kaczorek M., Idziorek T., Autran B., Bismuth G. HIV-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J. Clin. Invest. 1990; 86: 2117–2124
   PubMed Web of Science ®Google Scholar
• Hivroz C., Mazerolles F., Sola M., Fagard R., Graton S., Meloche S., Sékaly R., Fischer A. HIV gp120 and derived peptidesactivate protein tyrosine kinase p561ck in human CD4 T lymphocytes. Eur. J. Immunol. 1993; 23: 600–607
   PubMed Web of Science ®Google Scholar
• Kovacs J. A., Baseler M., Dewar R. J., Vogel S., Davey R. T., Falloon J., Polis M. A., Walker R. E., Stevens R., Salzman N. P., Metcalf J. A., Masur H., Lane H. C. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. N. Engl. Med. 1995; 332: 567–575
   PubMed Web of Science ®Google Scholar
• Teppler H., Kaplan G., Smith K., Cameron P., Montana A., Meyn P., Cohn Z. Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 1993; 167: 291–298
   PubMed Web of Science ®Google Scholar
• Teppler H., Kaplan O., Smith K. A., Montana A. L., Meyn P., Cohn Z. A. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. 1993; 177: 483–492
   PubMed Web of Science ®Google Scholar
• Kovacs J. A., Vogel S., Albert J. M., Falloon J., Davey R. T., Walker R. E., Polis M. A., Spooner K., Metcalf J. A., Baseler M., Fyfe G., Lane H. C. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 1996; 335: 1350–1356
   PubMed Web of Science ®Google Scholar
• Jacobson E. X., Pilaro F., Smith K. A. Rational interleukin 2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity. Proc. Natl. Acad. Sci. USA 1996; 93: 10405–10410
   PubMed Web of Science ®Google Scholar
• Clerici M., Shearer G. M. A Th1 Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 1993; 14: 107–110
   PubMedGoogle Scholar
• Boyle M. J., Berger M. F., Tschucnigg M., Valentine J. E., Kennedy B. G., Divjak M., Cooper D. A., Turner J. J., Penny R., Sewell W. A. Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients. Clin. Exp. Immunol. 1993; 92: 100–105
   PubMed Web of Science ®Google Scholar
• Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., MorelFourrier B., Galanaud P., Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis. Rheum. 1994; 37: 1647–1655
   PubMed Web of Science ®Google Scholar
• Romagnani S., DelPrete G., Manetti R., Ravina A., Annunziato F., DeCarli M., Mazzetti M., Piccinni M. P., D'Elios M. M., Parronchi P., Sampognaro S., Maggi E. Role of Th1/Th2 cytokines in HIV infection. Immunol. Rev. 1994; 140: 73–92
   PubMed Web of Science ®Google Scholar
• Zou W., Dulioust A., Fior R., Durand-Gasselin I., Boué F., Galanaud P., Emilie D. Increased Th2-type cytokine production in chronic HIV infection is due to IL-13 rather than IL-4. AIDS 1997; 11: 533–534
   PubMedGoogle Scholar
• Meyaard L., Hovenkamp E., Keet I., Hooibrink B., DeJong I., Otto S. A., Miedema F. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J. Immunol. 1996; 157: 2712–2718
   PubMedGoogle Scholar
• Zou W., Lackner A. A., Simon M., Durand-Gasselin I., Galanaud P., Desrosiers R. C., Emilie D. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 1997; 71: 1227–1236
   PubMed Web of Science ®Google Scholar
• Zou W., Coulomb A., Venet A., Foussat A., Berrebi D., Beyer C., Crevon M. C., Minty A., Couedel-Courteille A., Vivier E., Capron F., Galanaud P., Emilie D. Administration of IL-13 to SIV-infected macaques induction of intestinal epithelium atrophy, Submitted for publication
   Google Scholar
• Chehimi J., Starr S. E., Frank I., Rengaraju M., Jackson S. J., Llanes C., Kobayashi M., Perussia B., Young D., Nickbarg E., Wolff S. F., Trinchieri G. NK cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and HIV-infected patients. J. Exp. Med. 1992; 175: 789–796
   PubMed Web of Science ®Google Scholar
• Clerici M., Lucey D., Berzofsky J., Pinto L. A., Wynn T. A., Blatt S. P., Dolan M. J., Hendrix C. W., Wolf S. F., Shearer G. M. Restoration of HIV-specific cell-mediated immune responses by interleukin 12 in vitro. Science 1993; 262: 1721–1724
   PubMed Web of Science ®Google Scholar
• Uherova P., Connick E., Whinney S. M., Schlichtemeier R., Schooley R. T., Kuritzkes D. R. In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1. J. Inf. Dis. 1996; 174: 483–489
   PubMed Web of Science ®Google Scholar
• Landay A. L., Clerici M., Hashemi F., Kessler H., Berzofsky J. A., Shearer G. M. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of Interleukin (IL)-12 and Anti-IL-10. J. Inf. Dis. 1996; 173: 1085–1091
   PubMed Web of Science ®Google Scholar
• Blauvelt A., Chougnet C., Shearer G. M., Katz S. I. Modulation of T cell responses to recall antigens presented by langerhans cells in HIV-discordant identical twins by anti-Interleukin (IL)-10 antibodies and IL-12. J. Clin. Invest. 1996; 6: 1550–1555
   Google Scholar
• Clerici M., Wynn T. A., Berzofsky J. A., Blatt S. P., Hendrix C. W., Sher A., Coffman R. L., Shearer G. M. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with HIV. J. Clin. Invest 1994; 93: 768–777
   PubMed Web of Science ®Google Scholar
• Zhang M., Gong J., Lyer D. V., Jones B. E., Modlin R. L., Barnes P. F. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J. Clin. Invest. 1994; 94: 2435–2442
   PubMed Web of Science ®Google Scholar
• Blatt S. P., Hendrix C. W., Butzin C. A., Freeman T. M., Ward W. W., Hensley R. E., Melcher G. P., Donovan D. J., Boswell R. N. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann. Intern. Med. 1993; 119: 177–183
   PubMed Web of Science ®Google Scholar
• Lucey D. R., Melcher G. P., Hendrix C. W., Zajac R. A., Goetz D. W., Butzin C. A., Clerici M., Warner R. D., Abbadessa S., Hall K. The US air force HIV study 1985–1990: immunological analyses, seroconversion and the potential utility of a T-helper functional assay to predict change in CD4+ T-cell counts during early stage HIV infection. J. Inf. Dis. 1991; 164: 631–637
   PubMedGoogle Scholar
• Clerici M., Balotta C., Salvaggio A., Riva C., Trabattoni D., Papagno L., Berlusconi A., Rusconi S., Villa M. L., Moroni M., Galli M. Human Immunodeficiency Virus (HIV) phenotype and Interleukin-2/Interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996; 88: 574–579
   PubMed Web of Science ®Google Scholar
• Schuitemakern H., Meyaard L., Koostra N. A., Dubbes R., Otto S. A., Tersmette M., Heeney J. L., Miedema F. Lack of T cell dysfunction and programmed cell death in HIV type-1-infected chimpanzees correlates with absence of monocytotropic variants. J. Inf. Dis. 1993; 168: 1140–1147
   PubMedGoogle Scholar
• Mosier D. E., Gulizia R. J., Maclsaac P. D., Torbett B. E., Levy J. A. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 1993; 260: 689–692
   PubMedGoogle Scholar
• Ho D. D., Neuman A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 12–126
   Google Scholar
• Clerici M., Sarin A., Coffman R. L., Wynn T. A., Blatt S. P., Hendrix C. W., Wolf S. F., Shearer G. M., Henkart P. A. Type 1/type 2 cytokine modulation of T-cell programed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci USA 1994; 91: 11811–11815
   PubMed Web of Science ®Google Scholar
• Estaquier J., Idziorek T., Zou W., Emilie D., Farber C. M., Bourez J. M., Ameisen J. C. TH1/TH2 cytokines and T-cell death: preventive effect of IL-12 on activation induced and CD95 (FAS/APO-1) mediated apoptosis of CD4+ T cells from HIV-infected persons. J. Exp. Med. 1995; 182: 1759–1767
   PubMed Web of Science ®Google Scholar
• Maggi E., Giudizi M. G., Biagiotti R., Annunziato F., Manetti R., Piccinni M. P., Parronchi P., Sampognaro S., Giannarini L., Zuccati G., Romagnani S. Th2-like CD8+ T-cells showing B cell helper function and reduced cytolytic activity in HIV type 1 infection. J. Exp. Med. 1994; 180: 489–495
   PubMed Web of Science ®Google Scholar
• Marfaing-Koka A., Aubin J. T., Grangeot-Keros L., Portier A., Benattar C., Merrien D., Agut H., Aucouturier P., Autran B., Wijdenes J., Oalanaud P., Emilie D. In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. J. AIDS Hum. Retrovirol. 1995; 11(1996)59–68
   Google Scholar
• Agosti J. M., Coombs R. W., Collier A. C., Paradise M. A., Benedetti J. K., Jaffe H. S., Corey L. A randomized, double-blind, phase I/II trial of tumor necrosis factor and interferon-gamma for treatment of AIDS-related complex (Protocol 025 from the AIDS clinical trials group). AIDS Res. Hum. Retroviruses 1992; 8: 581–587
   PubMed Web of Science ®Google Scholar
• Levine J. D., Allan J. D., Tessitore J. H., Falcone N., Galasso F., Israel R. J., Groopman J. E. Recombinant human granulocyte-macrophage colony stimulating factor ameliorates Zidovudine induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS related complex. Blood 1991; 78: 3148–3154
   PubMedGoogle Scholar
• Walker R. E., Spooner K. M., Kelly G., McCloskey R. V., Woody J. N., Falloon J., Baseler M., Piscitelli S. C., Davey R. T., Polis M. A., Kovacs J. A., Masur H., Lane C. Inhibition of immunoreactive tumor necrosis factor-α by a chimeric antibody in patients infected with human immunodeficiency virus type 1. J. Inf. Dis. 1996; 174: 63–68
   PubMed Web of Science ®Google Scholar
• Lane H. C. Interferons in HIV and related diseases. AIDS 1994; 8: S19–S23
   Google Scholar
• Mackewicz C. E., Blackbourn D. J., Levy J. A. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 1995; 92: 2308–2312
   PubMed Web of Science ®Google Scholar
• Kinter A. L., Bende S. M., Hardy E. C., Jackson R., Fauci A. S. Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. Proc. Natl. Acad. Sci. USA 1995; 92: 10985–10989
   PubMed Web of Science ®Google Scholar
• Barker E., Machewicz C. E., Levy J. A. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: Implications for long-term survival. Proc. Natl. Acad. Sci. USA 1995; 92: 11135–11139
   PubMed Web of Science ®Google Scholar
• Baier M., Werner A., Bannert N., Metzner K., Kurth R. HIV suppression by interleukin-6. Nature 1995; 378: 563–564
   PubMed Web of Science ®Google Scholar
• Center D. M., Kornfeld H., Cruikshank W. W. Interleukin 16 and its function as a CD4 ligand. Immunol. Today 1996; 10: 476–481
   Google Scholar
• Mackewitz C. E., Levy J. A., Cruikshank W. W., Kornfeld H., Center D. M. Role of IL-16 in HIV replication. Nature 1996; 383: 488–489
   PubMedGoogle Scholar
• Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872–874
   PubMed Web of Science ®Google Scholar
• Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J. M., Arenzana-Seisdedos F., Schwartz O., Heard J. M., Clark-Lewis I., Legler D. F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833–835
   PubMed Web of Science ®Google Scholar
• Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/ fusion and blocks HIV-1 entry. Nature 1996; 382: 829–832
   PubMed Web of Science ®Google Scholar
• Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., Lusso P. Identification of RANTES, MIP-1 α and MIP-1 β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811–1815
   PubMed Web of Science ®Google Scholar
• Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272: 1955–1958
   PubMed Web of Science ®Google Scholar
• Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The β-Chemokine Receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135–1148
   PubMed Web of Science ®Google Scholar
• Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661–666
   PubMed Web of Science ®Google Scholar
• Drajic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667–673
   PubMedGoogle Scholar
• Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85: 1149–1158
   PubMed Web of Science ®Google Scholar
• Rucker J., Samson M., Doranz B. J., Libert F., Berson J. F., Yi Y., Smyth R. J., Collman R. G., Broder C. C., Vassart G., Doms R. W., Parmentier M. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996; 87: 437–446
   PubMed Web of Science ®Google Scholar
• Zhang L., Huang Y., He T., Cao Y., Ho D. D. HIV-1 subtype and second-receptor use. Nature 1996; 383: 768
   PubMed Web of Science ®Google Scholar
• Oravecz T., Pall M., Norcross M. A. β-Chemokine Inhibition of Monocytotropic HIV-1 Infection. J. Immunol. 1996; 157: 1329–1332
   PubMedGoogle Scholar
• Levy J. A. Infection by human immunodeficiency virus CD4 is not enough. N. Engl. J. Med. 1996; 14: 1528–1530
   Google Scholar
• Endres M. J., Clapham P. R., Marsh M., Ahuja M., Turner J. D., McKnight A., Thomas J. F., Stoebenauhaggarty B., Choe S., Vance P. J., Wells T. N.C., Power C. A., Sutterwala S. S., Doms R. W., Landau N. R., Hoxie J. A. CD4-independent infection by HIV-2 is mediated by fusin-CXCR4. Cell 1996; 87: 745–756
   PubMed Web of Science ®Google Scholar
• Canque B. B., Rosenzwajg M., Gey A., Tartour E., Fridman W. H., Gluckman J. C. Macrophage inflammatory protein-1α is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 1996; 87: 2011–2019
   PubMed Web of Science ®Google Scholar
• Schmidtmayerova H., Nottet H., Nuovo G., Raabe T., Flanagan C. R., Dubrovsky L., Gendelman H. E., Cerami A., Bukrinsky M., Sherry B. Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 1996; 93: 700–704
   PubMed Web of Science ®Google Scholar
• Schmidtmayerova H., Sherry B., Bukinsky M. Chemokines and HIV replication. Nature 1996; 382: 767
   PubMed Web of Science ®Google Scholar
• Arenzana-Seisdedos F., Virelizier J. L., Rousset D., Clark-Lewis I., Loetscher P., Moser B., Baggiolini M. HIV blocked by chemokine antagonist. Nature 1996; 383: 400
   PubMed Web of Science ®Google Scholar
• Paxton W. A., Martin S. R., Tse D., O'Brien T. R., Skurnick J., VanDevanter N. L., Padian N., Braun J. F., Kotler D. P., Wolinsky S. M., Koup R. A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Medicine 1996; 4: 412–417
   Google Scholar
• Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367–377
   PubMed Web of Science ®Google Scholar
• Samson M., Libert F., Doranz B. J., Rucker J., Leisnard C., Farber C. M., Saragosti S., Lapouméroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R. J., Collman R. G., Doms R. W., Vassart G., Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-S chemokine receptor gene. Nature 1996; 382: 722–725
   PubMed Web of Science ®Google Scholar
• Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Gomperts E., Donfiels S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1856–1862
   PubMed Web of Science ®Google Scholar